MLTX RSI Chart
Last 7 days
-1.4%
Last 30 days
-10.2%
Last 90 days
-33.6%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Feb 29, 2024 | santos da silva jorge | sold | -264,919 | 55.89 | -4,740 | chief executive officer |
Feb 28, 2024 | reich kristian | sold | -1,544,950 | 55.00 | -28,090 | chief scientific officer |
Feb 28, 2024 | reich kristian | sold | -1,755,050 | 55.00 | -31,910 | chief scientific officer |
Feb 28, 2024 | santos da silva jorge | sold | -3,083,580 | 55.00 | -56,065 | chief executive officer |
Feb 27, 2024 | reich kristian | sold | -1,618,700 | 55.00 | -29,431 | chief scientific officer |
Feb 27, 2024 | reich kristian | sold | -1,622,000 | 55.00 | -29,491 | chief scientific officer |
Feb 27, 2024 | santos da silva jorge | sold | -3,454,550 | 55.00 | -62,810 | chief executive officer |
Feb 21, 2024 | santos da silva jorge | sold | -62,178 | 55.27 | -1,125 | chief executive officer |
Feb 21, 2024 | reich kristian | sold | -31,465 | 55.3 | -569 | chief scientific officer |
Feb 21, 2024 | reich kristian | sold | -28,152 | 55.31 | -509 | chief scientific officer |
Which funds bought or sold MLTX recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 08, 2024 | TD Asset Management Inc | reduced | -2.41 | -2,378,440 | 10,251,600 | 0.01% |
May 08, 2024 | KBC Group NV | new | - | 28,000 | 28,000 | -% |
May 07, 2024 | TimesSquare Capital Management, LLC | reduced | -57.14 | -18,996,000 | 10,523,000 | 0.15% |
May 07, 2024 | Headlands Technologies LLC | sold off | -100 | -5,435 | - | -% |
May 07, 2024 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | reduced | -66.2 | -9,295,770 | 3,634,690 | -% |
May 07, 2024 | Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | added | 0.1 | -2,314,600 | 11,514,200 | 1.78% |
May 07, 2024 | NEW YORK STATE COMMON RETIREMENT FUND | added | 8,983 | 410,000 | 415,000 | -% |
May 07, 2024 | Swiss National Bank | unchanged | - | -358,648 | 1,773,120 | -% |
May 07, 2024 | Arizona State Retirement System | reduced | -1.18 | -53,773 | 248,237 | -% |
May 06, 2024 | TEACHER RETIREMENT SYSTEM OF TEXAS | reduced | -3.54 | -50,000 | 201,000 | -% |
Unveiling MoonLake Immunotherapeutics's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to MoonLake Immunotherapeutics)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 47.0B | 6.8B | -7.88 | 6.87 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.2B | 2.0B | -57.69 | 9.56 | ||||
BMRN | 15.5B | 2.5B | 75.54 | 6.28 | ||||
INCY | 12.0B | 3.8B | 16.12 | 3.19 | ||||
MID-CAP | ||||||||
BBIO | 5.4B | 107.9M | -9.84 | 48.09 | ||||
APLS | 5.2B | 524.1M | -12.38 | 9.86 | ||||
AXSM | 3.5B | 251.0M | -11.8 | 13.94 | ||||
ARWR | 3.1B | 240.7M | -10.34 | 12.18 | ||||
ACAD | 2.5B | 726.4M | -40.84 | 3.45 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 28.42 | 4.5 | ||||
NVAX | 627.0M | 983.7M | -1.15 | 0.64 | ||||
CRBP | 467.5M | 881.7K | -13.85 | 481.06 | ||||
INO | 260.8M | 4.9M | -1.93 | 53.59 | ||||
IBIO | 6.4M | 2.1M | -0.24 | 2.14 |
MoonLake Immunotherapeutics News
Balance Sheet | ||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 |
Assets | 7.1% | 564 | 527 | 500 | 507 | 67.00 | 77.00 | 89.00 | 98.00 | 12.00 | 10.00 | 116 | 116 | 116 | 117 | - |
Current Assets | 7.7% | 554 | 514 | 500 | 506 | 67.00 | 77.00 | 89.00 | 98.00 | 12.00 | 10.00 | 1.00 | 1.00 | 1.00 | 2.00 | - |
Cash Equivalents | 1.6% | 458 | 451 | 318 | 502 | 50.00 | 40.00 | 41.00 | 93.00 | 9.00 | 8.00 | 1.00 | 2.00 | 1.00 | - | - |
Net PPE | 58.9% | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - |
Liabilities | -10.1% | 12.00 | 13.00 | 11.00 | 8.00 | 8.00 | 8.00 | 6.00 | 4.00 | 37.00 | 21.00 | 6.00 | 4.00 | 4.00 | 4.00 | - |
Current Liabilities | -10.6% | 9.00 | 10.00 | 10.00 | 7.00 | 7.00 | 8.00 | 6.00 | 4.00 | 37.00 | 21.00 | 2.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Short Term Borrowings | - | - | - | - | - | - | - | - | - | - | 15.00 | - | - | - | - | - |
Shareholder's Equity | 11.4% | 552 | 496 | 425 | 499 | 59.00 | 49.00 | 83.00 | 95.00 | 24.00 | - | - | 1.00 | 5.00 | 5.00 | 0.00 |
Retained Earnings | -11.7% | -130 | -116 | -109 | -99.79 | -89.66 | -80.65 | -68.79 | -58.68 | -69.52 | -53.64 | -4.84 | -0.32 | -0.17 | -2.52 | 0.00 |
Additional Paid-In Capital | 9.9% | 670 | 610 | 531 | 590 | 131 | 129 | 124 | 122 | 44.00 | 42.00 | - | 5.00 | 5.00 | 5.00 | 0.00 |
Shares Outstanding | 27.5% | 63.00 | 49.00 | 45.00 | 44.00 | 39.00 | 29.00 | 26.00 | 20.00 | 53.00 | 8.00 | 2.00 | 16.00 | - | 6.00 | 3.00 |
Minority Interest | -44.8% | 10.00 | 18.00 | 65.00 | 9.00 | 17.00 | 20.00 | 27.00 | 31.00 | - | - | - | - | - | - | - |
Float | - | - | - | - | 1,120 | - | - | - | 34.00 | - | - | - | 119 | - | - | - |
Cashflow (Quarterly) | |||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 |
Cashflow From Operations | -21.1% | -14,948 | -12,344 | -9,250 | -12,158 | -9,024 | -11,595 | -9,351 | -20,760 | -14,185 | 27,112 | -2,018 | -25,596 | -107 | - |
Share Based Compensation | 4.5% | 1,677 | 1,606 | 1,426 | 1,498 | 2,577 | 2,597 | 2,585 | 2,484 | 1,989 | - | - | - | - | - |
Cashflow From Investing | -124.6% | -28,804 | 116,867 | -174,375 | 12,676 | 19,649 | 9,901 | -42,226 | 2* | -16.01 | - | -11.65 | - | - | - |
Cashflow From Financing | 79.4% | 50,978 | 28,416 | - | 451,285 | - | 4.00 | - | 104,685 | 15,004 | -28,322 | 498 | 27,824 | -58.06 | - |
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Operating expenses | ||
Research and development | $ (31,801,880) | $ (42,048,954) |
General and administrative | (22,321,216) | (23,012,463) |
Total operating expenses | (54,123,096) | (65,061,417) |
Operating loss | (54,123,096) | (65,061,417) |
Other income, net | 10,138,367 | 591,732 |
Loss before income tax | (43,984,729) | (64,469,685) |
Income tax expense | (94,388) | (36,366) |
Net loss | (44,079,117) | (64,506,051) |
Of which: net loss attributable to controlling interests shareholders | (36,007,260) | (49,973,249) |
Of which: net loss attributable to noncontrolling interests shareholders | (8,071,857) | (14,532,802) |
Net unrealized gain on marketable securities and short-term investments | 2,330,101 | 390,753 |
Actuarial income (loss) on employee benefit plans | (336,579) | 269,893 |
Other comprehensive income | 1,993,522 | 660,646 |
Comprehensive loss | (42,085,595) | (63,845,405) |
Comprehensive loss attributable to controlling interests shareholders | (34,511,723) | (49,437,461) |
Comprehensive loss attributable to noncontrolling interests | $ (7,573,872) | $ (14,407,944) |
Weighted-average number of shares, basic (in shares) | 49,122,534 | 29,361,353 |
Weighted-average number of shares, diluted (in shares) | 49,122,534 | 29,361,353 |
Basic net loss per share attributable to controlling interest shareholders (USD per share) | $ (0.73) | $ (1.70) |
Diluted net loss per share attributable to controlling interest shareholders (USD per share) | $ (0.73) | $ (1.70) |
Common Class A | ||
Operating expenses | ||
Weighted-average number of shares, basic (in shares) | 49,122,534 | 29,361,353 |
Weighted-average number of shares, diluted (in shares) | 49,122,534 | 29,361,353 |
Basic net loss per share attributable to controlling interest shareholders (USD per share) | $ (0.73) | $ (1.70) |
Diluted net loss per share attributable to controlling interest shareholders (USD per share) | $ (0.73) | $ (1.70) |
CONSOLIDATED BALANCE SHEETS - USD ($) | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 451,169,337 | $ 39,505,627 |
Short-term marketable debt securities | 59,838,900 | 32,609,108 |
Other receivables | 1,056,862 | 217,129 |
Prepaid expenses - current | 2,102,203 | 4,179,468 |
Total current assets | 514,167,302 | 76,511,332 |
Non-current assets | ||
Operating lease right-of-use assets | 3,628,480 | 282,580 |
Property and equipment, net | 320,865 | 49,389 |
Prepaid expenses - non-current | 8,423,468 | 0 |
Total non-current assets | 12,372,813 | 331,969 |
Total assets | 526,540,115 | 76,843,301 |
Current liabilities | ||
Trade and other payables | 1,837,684 | 254,972 |
Short-term portion of operating lease liabilities | 1,197,876 | 153,629 |
Accrued expenses and other current liabilities | 6,930,120 | 7,256,845 |
Total current liabilities | 9,965,680 | 7,665,446 |
Non-current liabilities | ||
Long-term portion operating lease liability | 2,499,990 | 128,951 |
Pension liability | 583,426 | 282,206 |
Total non-current liabilities | 3,083,416 | 411,157 |
Total liabilities | 13,049,096 | 8,076,603 |
Commitments and contingencies | ||
Equity (deficit) | ||
Additional paid-in capital | 609,969,236 | 129,192,291 |
Accumulated deficit | (116,657,472) | (80,650,212) |
Accumulated other comprehensive income | 2,357,621 | 350,946 |
Total shareholders’ equity | 495,675,683 | 48,898,296 |
Noncontrolling interests | 17,815,336 | 19,868,402 |
Total equity | 513,491,019 | 68,766,698 |
Total liabilities and equity | 526,540,115 | 76,843,301 |
Common Class A | ||
Equity (deficit) | ||
Common Shares | 6,047 | 3,898 |
Common Class C | ||
Equity (deficit) | ||
Common Shares | $ 251 | $ 1,373 |